1. Home
  2. CRL vs CAVA Comparison

CRL vs CAVA Comparison

Compare CRL & CAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Charles River Laboratories International Inc.

CRL

Charles River Laboratories International Inc.

HOLD

Current Price

$181.34

Market Cap

8.6B

Sector

Health Care

ML Signal

HOLD

Logo CAVA Group Inc.

CAVA

CAVA Group Inc.

HOLD

Current Price

$73.01

Market Cap

9.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRL
CAVA
Founded
1947
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.6B
9.2B
IPO Year
1999
2023

Fundamental Metrics

Financial Performance
Metric
CRL
CAVA
Price
$181.34
$73.01
Analyst Decision
Buy
Buy
Analyst Count
12
23
Target Price
$198.27
$91.00
AVG Volume (30 Days)
825.1K
3.3M
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.20
Revenue
$1,857,601,000.00
$1,179,664,000.00
Revenue This Year
N/A
$25.71
Revenue Next Year
$3.04
$20.57
P/E Ratio
N/A
$360.60
Revenue Growth
10.48
22.41
52 Week Low
$143.06
$43.41
52 Week High
$228.88
$98.79

Technical Indicators

Market Signals
Indicator
CRL
CAVA
Relative Strength Index (RSI) 58.25 36.15
Support Level $161.39 $60.54
Resistance Level $184.75 $72.93
Average True Range (ATR) 8.71 3.94
MACD 2.64 -0.62
Stochastic Oscillator 85.03 16.34

Price Performance

Historical Comparison
CRL
CAVA

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

About CAVA CAVA Group Inc.

Cava Group Inc owns and operates a chain of restaurants. It operates a Mediterranean-inspired fast-casual restaurant brand offering menu items. The company's dips, spreads, and dressings are centrally produced and sold in grocery stores. The company's operations are conducted as two reportable segments: i) CAVA: It includes the operations of all company-owned CAVA restaurants, and ii) CAVA Foods: It includes the production of dips, spreads, and certain dressing bases used in CAVA restaurants as well as sales from the Company's consumer packaged goods business. The company generates the majority of its revenue from the CAVA segment.

Share on Social Networks: